News Hub: Comparing Apples with Exxons
[marketwatch 2B597C7A-C7A1-429F-8534-5F55A427E4D2] News Hub: Comparing Apples with Exxons […]
[marketwatch 2B597C7A-C7A1-429F-8534-5F55A427E4D2] News Hub: Comparing Apples with Exxons […]
Advance Auto Parts Inc. ( AAP ) reported a net income of $113.6 million in the second quarter of fiscal 2011, which was 12.6% higher from $100.9 million in the year-ago quarter. However, on per share basis, earnings improved 26% to $1.46 from $1.16 a year ago due to a decline in average shares outstanding to 77.4 million from 86.4 million in the second quarter of fiscal 2011. […]
[marketwatch A6A66A72-355A-4801-82D1-162707AE4789] News Hub:Economists Surveyed See Double Dip Risk […]
[marketwatch A6A66A72-355A-4801-82D1-162707AE4789] digits: WSJ Economists Survey: Risk of Double Dip […]
[cnbc 3000038870] Discussing the new bans on short positions in Belgium, France, Italy and Spain, with the Fast money traders. […]
[thestreet 1105792086001] Stocks Up Ahead of Consumer Spending Report […]
[marketwatch C6BC41D2-BEFB-43A0-8330-001931D0C934] News Hub: Cisco, Jobs Fuel Stock Market Rally […]
[marketwatch 844DBA89-CCB4-48AC-BD4C-7A89384CB8D3] S&P 500 Index Futures Signal More Pain Ahead […]
Dominion Resources Inc. ( D ) has sold $450 million unsecured notes yielding 1.95% interest per year and maturing on August 15, 2016. […]
Gamers are headed for a fantasy delight with Activision Blizzard Inc’s ( ATVI ) for PROTOTYPE 2 , for which the pre-order promotion has started in partnership with GameStop Corp. ( GME ) . PROTOTYPE 2 is the sequel to Radical Entertainment's best-selling game PROTOTYPE […]
[cnbc 3000038706] CNBC’s Melissa Lee and the Fast Money traders discuss the day’s top trades and the stocks they’ll be watching tomorrow. […]
Companhia de Saneamento Basico do Estado de São Paulo or SABESP ( SBS ) recently announced its tariff adjustment as approved by the São Paulo State Sanitation and Energy Regulatory Agency (ARSESP) on August 9, 2011. The regulatory agency approved a tariff readjustment index of 6.83% for SABESP, which the company can apply linearly to all categories of water and sewage consumers as of September 9, 2011. […]
Diagnostic test kit maker Meridian Bioscience ( VIVO ) has launched its new C. difficile (Clostridium difficile) test dubbed Immuno Card C. difficile GDH in Europe […]
UDR, Inc. ( UDR ), a leading multifamily real estate investment trust (REIT), reported second quarter 2011 FFO (funds from operations) of $63.6 million or 31 cents per share compared to $45.7 million or 27 cents in the year-earlier quarter. Funds from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income […]
Buoyed by favorable trends in the refining industry along with the company's initiatives to improve reliability and reduce operating costs, we have upgraded independent oil refiner and marketer Western Refining Inc. ( WNR ) to Outperform from Neutral. An uptick in economic activity overseas (mainly in China and India) and prospects for higher fuel demand in the U.S. […]
The Provident Bank Completes Acquisition of Beacon Trust Company and Beacon Global Asset Management, Inc. PR Newswire MORRISTOWN, N.J., Aug. 11, 2011 MORRISTOWN, N.J. […]
AutoNation Inc. ( AN ) revealed a 4% fall in new vehicle sales to 18,949 units in July due to a sluggish economy as the economy expanded at a 1.3% annual rate in the second quarter of 2011 as well as the adverse impact from the earthquake in Japan on March 11. Sales of the Domestic brands, which comprise stores that sell vehicles manufactured by General Motors ( GM ), Ford Motor Co. […]
The world’s biggest HIV drug maker, Gilead Sciences, Inc. ( GILD ) received a huge boost following approval by the US Food and Drug Administration (FDA) for its once-daily single tablet regimen (STR) for the treatment of HIV in previously untreated adults. The tablet, which will be marketed as Complera, is a combination of Gilead’s most popular HIV drug, Truvada (a fixed-dose, once-daily tablet containing Gilead's Viread and Emtriva), and Johnson and Johnson ’s ( JNJ ) recently approved HIV drug Edurant. […]
Medical imaging solutions provider VirtualScopics ’( VSCP ) second-quarter 2011 earnings of a penny per share matched the Zacks Consensus Estimate and the year-ago earnings. The Rochester, New York-based company’s net income (attributable to common stockholders) rose roughly 6% year over year to $315,650. Revenues surged 20% year over year to $3.85 million, but modestly missed the Zacks Consensus Estimate of $4 million […]
Rapid Fire Marketing: Update to Shareholders PR Newswire CARSON CITY, Nev., Aug. 11, 2011 CARSON CITY, Nev. […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes